MapLight Therapeutics Inc
MPLT18.550USD
-0.680-3.54%
Close 03/27, 16:00（ET）Quotes delayed by 15 min
768.51MMarket Cap
LossP/E TTM
More Details of Company
MapLight Therapeutics Inc Info
Ticker Symbol- -
Company name- -
IPO date- -
CEO- -
Number of employees- -
Security type- -
Fiscal year-end- -
Address- -
City- -
Stock exchange- -
Country- -
Postal code- -
Phone- -
Website- -
Ticker Symbol- -
IPO date- -
CEO- -
Company Executives of MapLight Therapeutics Inc
Name
Name/Position
Position
Shareholding
Change
Dr. Anatol Kreitzer, Ph.D.
Dr. Anatol Kreitzer, Ph.D.
Chief Discovery Officer
Chief Discovery Officer
259.93K
+2.32%
Mr. Jonathan Gillis, CPA
Mr. Jonathan Gillis, CPA
Chief Accounting Officer, Chief Administrative Officer
Chief Accounting Officer, Chief Administrative Officer
254.52K
+2.37%
Ms. Erin Pennock Foff, M.D., Ph.D.
Ms. Erin Pennock Foff, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
51.47K
+25.96%
Mr. Vishwas Setia
Mr. Vishwas Setia
Chief Financial Officer
Chief Financial Officer
25.54K
+30.27%
Mr. Robert Malenka, M.D., Ph.D.
Mr. Robert Malenka, M.D., Ph.D.
Director
Director
--
--
Dr. Christopher A. Kroeger, M.D.
Dr. Christopher A. Kroeger, M.D.
Co-Founder, President, Chief Executive Officer, Director
Co-Founder, President, Chief Executive Officer, Director
--
--
Mr. James Lillie, Ph.D.
Mr. James Lillie, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Mr. Kristopher L. Hanson
Mr. Kristopher L. Hanson
General Counsel
General Counsel
--
--
Dr. Timothy Garnett
Dr. Timothy Garnett
Independent Director
Independent Director
--
--
Ms. Nanna Luneborg, Ph.D.
Ms. Nanna Luneborg, Ph.D.
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Anatol Kreitzer, Ph.D.
Dr. Anatol Kreitzer, Ph.D.
Chief Discovery Officer
Chief Discovery Officer
259.93K
+2.32%
Mr. Jonathan Gillis, CPA
Mr. Jonathan Gillis, CPA
Chief Accounting Officer, Chief Administrative Officer
Chief Accounting Officer, Chief Administrative Officer
254.52K
+2.37%
Ms. Erin Pennock Foff, M.D., Ph.D.
Ms. Erin Pennock Foff, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
51.47K
+25.96%
Mr. Vishwas Setia
Mr. Vishwas Setia
Chief Financial Officer
Chief Financial Officer
25.54K
+30.27%
Mr. Robert Malenka, M.D., Ph.D.
Mr. Robert Malenka, M.D., Ph.D.
Director
Director
--
--
Dr. Christopher A. Kroeger, M.D.
Dr. Christopher A. Kroeger, M.D.
Co-Founder, President, Chief Executive Officer, Director
Co-Founder, President, Chief Executive Officer, Director
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Fri, Feb 27
Updated: Fri, Feb 27
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Catalyst4 Inc
46.42%
Novo Holdings A/S
8.69%
Forbion Capital Partners
7.60%
T. Rowe Price Investment Management, Inc.
6.60%
Goldman Sachs & Company, Inc.
2.54%
Other
28.16%
Shareholders
Shareholders
Proportion
Catalyst4 Inc
46.42%
Novo Holdings A/S
8.69%
Forbion Capital Partners
7.60%
T. Rowe Price Investment Management, Inc.
6.60%
Goldman Sachs & Company, Inc.
2.54%
Other
28.16%
Shareholder Types
Shareholders
Proportion
Corporation
45.42%
Venture Capital
20.82%
Investment Advisor
15.30%
Investment Advisor/Hedge Fund
5.27%
Hedge Fund
3.51%
Individual Investor
3.33%
Research Firm
2.51%
Private Equity
1.34%
Endowment Fund
0.44%
Other
2.06%
Institutional Shareholding
Updated: Wed, Jan 21
Updated: Wed, Jan 21
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q4
4
3.81M
0.06%
--
2025Q4
25
7.61M
16.77%
+7.34M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Catalyst4 Inc
19.70M
43.41%
+19.70M
--
Oct 28, 2025
Novo Holdings A/S
3.69M
8.13%
+3.69M
--
Oct 28, 2025
T. Rowe Price Investment Management, Inc.
11.80K
0.03%
+1.04K
+9.68%
Dec 31, 2025
The Vanguard Group, Inc.
44.63K
0.1%
+23.86K
+114.87%
Nov 30, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
